Acro Biomedical Co., Ltd.
OTC: ACBM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yu-Ting Su
- Employees
- 1
- Headquarters
- Fishers, United States
- IPO year
- 2021
- Market cap
- $1.6M
- Website
- https://acrobiomedicalco.com
Loading ACBM…
Loading profile data…Frequently asked questions about ACBM
What does Acro Biomedical Co., Ltd. (ACBM) do?
Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until...
Where does ACBM trade?
Acro Biomedical Co., Ltd. (ACBM) trades on the Other OTC.
What sector is ACBM in?
Acro Biomedical Co., Ltd. (ACBM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Acro Biomedical Co., Ltd.?
Yu-Ting Su is the chief executive officer of Acro Biomedical Co., Ltd. (ACBM).
Where is Acro Biomedical Co., Ltd. headquartered?
Acro Biomedical Co., Ltd. is headquartered in United States.
Does ACBM pay a dividend?
Acro Biomedical Co., Ltd. (ACBM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACBM go public?
Acro Biomedical Co., Ltd. (ACBM) completed its initial public offering in 2021.